Long term α-MSH treatment using a mini osmotic pump has significant potential for prevention of and therapy for diabetes-induced systolic or diastolic dysfunction which is not associated with Ca2+ sensitivity and/or vascular status. Here, STAMBP is linked to diabetes mellitus.